 |
|
Immunotherapy is an alternative approach to conventional cancer therapies. Out of wide range of therapy approaches immune checkpoint pathway proteins are promising targets. Abeomics offers biologically active immune checkpoint proteins which are functionally characterized. Abeomics also provides Reporter cell lines and Antibodies for Immuno Oncology research.
|
| Immune Checkpoint Recombinant Proteins (New Releases) |
|
|
|
|
| Immune Checkpoint Proteins |
|
|
| |
|
|
